| A non-hallucinogenic LSD analog with therapeutic potential for mood disorders V Lewis, EM Bonniwell, JK Lanham, A Ghaffari, H Sheshbaradaran, ... Cell Reports 42 (3), 2023 | 34 | 2023 |
| Canada’s Colonial Genocide of Indigenous Peoples: A Review of the Psychosocial and Neurobiological Processes Linking Trauma and Intergenerational Outcomes K Matheson, A Seymour, J Landry, K Ventura, E Arsenault, H Anisman International Journal of Environmental Research and Public Health 19 (11), 6455, 2022 | 15 | 2022 |
| Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders AAV V Lewis, B Rodrigue, E Arsenault, M Zhang, F Taghavi-Abkuh, W Castro ... Journal of Neurochemistry, 2022 | 7* | 2022 |
| Linking depression, mRNA translation, and serotonin E Arsenault, AA Ahmed, A Daneshmend, Z Jihad-Mohamad, ... The Neuroscience of Depression, 79-88, 2021 | 1 | 2021 |
| The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s … FC Ribeiro, D Cozachenco, EK Argyrousi, A Staniszewski, S Wiebe, ... bioRxiv, 2023.08. 03.551808, 2023 | | 2023 |
| 45. A Non-Hallucinogenic LSD Analogue With Therapeutic Potential in Mood Disorders V Lewis, E Arsenault, MA Bautista-Carro, FF Taghavi-Abkuh, F El Sayegh, ... Biological Psychiatry 93 (9), S112, 2023 | | 2023 |
| A Non-Hallucinogenic LSD Analog With Therapeutic Potential for Mood Disorders AA Valles, V Lewis, A Telfer, E Arsenault, FF Taghavi-Abkuh, F El Sayegh, ... NEUROPSYCHOPHARMACOLOGY 47 (SUPPL 1), 269-270, 2022 | | 2022 |
| Correction of mTORC1-mediated protein synthesis rescues memory in mouse models of Alzheimer's disease D Cozachenco, FC Ribeiro, EK Argyrousi, A Staniszewski, S Wiebe, ... JOURNAL OF NEUROCHEMISTRY 162, 43-43, 2022 | | 2022 |
Argel Aguilar-VallesAssistant Professor, Carleton UniversityGeverifieerd e-mailadres voor cunet.carleton.ca
